Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationally. Its products include human serum albumin; intravenous human immunoglobulin; rabies immunoglobulin; tetanus immunoglobulin; hepatitis B immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex concentrate; lyophilized intravenous hepatitis B immunoglobulin; human coagulation factors VIII; human fibrinogen; recombinant human coagulation factor VIII for injection; and other blood products. The company was founded in 1966 and is headquartered in Beijing, China.
Frequently asked questions
What sector does Beijing Tiantan Biological Products Corp Ltd (600161) operate in?
Beijing Tiantan Biological Products Corp Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Beijing Tiantan Biological Products Corp Ltd (600161) current stock price?
As of the latest data, Beijing Tiantan Biological Products Corp Ltd stock price is CN¥12.17, with a previous close of CN¥12.10. Beijing Tiantan Biological Products Corp Ltd gained CN¥0.07 in the last trading session, representing a 0.58% increase.
What is Beijing Tiantan Biological Products Corp Ltd (600161) current market capitalization?
Beijing Tiantan Biological Products Corp Ltd market cap is approximately 24.06 billion.
What is Beijing Tiantan Biological Products Corp Ltd (600161) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.38, and the forward EPS is CN¥0.41.
What is Beijing Tiantan Biological Products Corp Ltd (600161) Price-to-Earnings (P/E) ratio?
Beijing Tiantan Biological Products Corp Ltd current P/E ratio is 32.03, with a forward P/E of 29.55.
Does Beijing Tiantan Biological Products Corp Ltd (600161) pay dividends?
No. Beijing Tiantan Biological Products Corp Ltd does not pay a dividend.
How did Beijing Tiantan Biological Products Corp Ltd (600161) perform in its most recent earnings report?
In the last report (June 30, 2026), Beijing Tiantan Biological Products Corp Ltd posted an EPS surprise of -50% and a revenue surprise of -14.39%.
What is Beijing Tiantan Biological Products Corp Ltd (600161) beta (volatility) score?
Beijing Tiantan Biological Products Corp Ltd has a beta of 0.218, indicating lower volatility than the overall market.
